Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Jay Kincannon

Concepts (98)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hair Diseases
2
2016
8
0.620
Why?
Lichen Sclerosus et Atrophicus
1
2012
7
0.420
Why?
Skin Diseases, Vesiculobullous
1
2012
8
0.420
Why?
Neck
1
2012
99
0.390
Why?
Dermatitis
2
2024
36
0.310
Why?
Dermatitis, Atopic
2
2024
39
0.290
Why?
Nevus, Epithelioid and Spindle Cell
1
2005
15
0.260
Why?
Lupus Erythematosus, Cutaneous
1
2024
2
0.230
Why?
Syphilis
1
2024
27
0.220
Why?
Medication Adherence
1
2024
129
0.210
Why?
Hyperoxaluria
1
2022
4
0.210
Why?
Hyperoxaluria, Primary
1
2022
3
0.210
Why?
Urolithiasis
1
2022
4
0.210
Why?
Skin Diseases, Genetic
1
2023
8
0.210
Why?
Dermatology
1
2024
52
0.210
Why?
Lupus Erythematosus, Systemic
1
2023
68
0.200
Why?
Eosinophilia
1
2023
36
0.200
Why?
Diagnosis, Differential
2
2016
1041
0.180
Why?
Kidney Failure, Chronic
1
2022
199
0.180
Why?
Dermatologic Surgical Procedures
1
2020
34
0.180
Why?
Skin Neoplasms
1
2005
487
0.170
Why?
Lasers, Solid-State
1
2020
32
0.170
Why?
Veins
1
2020
71
0.170
Why?
Erythrasma
1
1998
1
0.160
Why?
Vascular Malformations
1
2020
98
0.150
Why?
Protein Synthesis Inhibitors
1
1998
18
0.150
Why?
Child, Preschool
6
2020
3896
0.150
Why?
Erythema
2
2023
38
0.150
Why?
Clarithromycin
1
1998
38
0.150
Why?
Warts
2
2010
13
0.150
Why?
Patch Tests
1
1997
6
0.140
Why?
Dermatitis, Contact
1
1997
3
0.140
Why?
Antigens, Fungal
2
2010
23
0.140
Why?
Skin
1
2020
416
0.140
Why?
Hair
1
2016
29
0.130
Why?
Immunotherapy
2
2010
235
0.120
Why?
Humans
17
2024
50201
0.120
Why?
Female
10
2022
26829
0.110
Why?
Anti-Bacterial Agents
1
1998
744
0.100
Why?
Hemorrhage
1
2012
196
0.090
Why?
Biopsy
1
2012
592
0.090
Why?
Candida
1
2010
60
0.090
Why?
Adolescent
5
2020
6459
0.090
Why?
Child
5
2024
6862
0.080
Why?
Neprilysin
1
2008
14
0.080
Why?
Hamartoma Syndrome, Multiple
1
2008
15
0.080
Why?
Antigens, CD34
1
2008
65
0.080
Why?
Proto-Oncogene Proteins c-bcl-2
1
2008
127
0.070
Why?
Immunohistochemistry
2
2008
973
0.070
Why?
Upper Extremity
1
2005
43
0.060
Why?
Biopsy, Needle
1
2005
182
0.060
Why?
Young Adult
3
2022
4052
0.060
Why?
Dermatologic Agents
1
2004
10
0.060
Why?
Skin Diseases
2
2003
114
0.060
Why?
Tacrolimus
1
2004
57
0.060
Why?
Infant
2
2023
3584
0.050
Why?
Antigens, Viral
1
2003
43
0.050
Why?
Follow-Up Studies
2
2005
2188
0.050
Why?
Oxalates
1
2022
11
0.050
Why?
Immunosuppressive Agents
1
2004
226
0.050
Why?
Rare Diseases
1
2023
43
0.050
Why?
Caregivers
1
2024
213
0.050
Why?
Risk Assessment
1
2005
1255
0.050
Why?
Photography
1
2020
32
0.040
Why?
Single-Blind Method
1
2020
114
0.040
Why?
Eyelashes
1
1999
3
0.040
Why?
Lymphedema
1
1999
43
0.040
Why?
Adult
3
2022
13486
0.040
Why?
Corynebacterium
1
1998
1
0.040
Why?
Treatment Outcome
3
2020
5203
0.040
Why?
Prospective Studies
2
2020
2396
0.040
Why?
Injections, Intralesional
2
2010
31
0.040
Why?
Conjunctival Neoplasms
1
1997
6
0.040
Why?
Sebaceous Glands
1
1997
13
0.040
Why?
Eye Abnormalities
1
1997
24
0.030
Why?
Choristoma
1
1997
23
0.030
Why?
Facial Neoplasms
1
1997
22
0.030
Why?
Nevus, Pigmented
1
1997
34
0.030
Why?
Ectodermal Dysplasia
1
1996
6
0.030
Why?
Tooth Abnormalities
1
1996
12
0.030
Why?
Infant, Newborn
1
2023
2770
0.030
Why?
Retrospective Studies
2
2020
6190
0.030
Why?
Male
5
2020
25572
0.020
Why?
Immunity, Cellular
1
2010
69
0.020
Why?
Brain
1
1997
1311
0.020
Why?
Epidermal Cyst
1
2008
12
0.020
Why?
Hair Follicle
1
2008
34
0.020
Why?
Syndrome
2
1999
239
0.020
Why?
Mumps
1
2003
13
0.010
Why?
Candidiasis
1
2003
114
0.010
Why?
Severity of Illness Index
1
2003
959
0.010
Why?
Lacrimal Apparatus Diseases
1
1997
6
0.010
Why?
Optic Disk
1
1997
21
0.010
Why?
Dental Caries
1
1996
7
0.010
Why?
Pedigree
1
1996
125
0.010
Why?
Middle Aged
1
2010
12356
0.010
Why?
Alopecia
1
1996
37
0.010
Why?
Magnetic Resonance Imaging
1
1997
1529
0.010
Why?
Kincannon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description